Cellular Goods PLC Cellular Goods open shipping to 4 more EU markets (6158T)

TIDMCBX

RNS Number : 6158T

Cellular Goods PLC

16 November 2023

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

16 November 2023

Cellular Goods plc

("Cellular Goods" or "The Company")

Cellular Goods' products available for purchase in Austria, Italy, Portugal and Spain

Cellular Goods (LSE: CBX), a UK based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, is pleased to announce that products in its 'Look Better' skincare range are now available to purchase in Austria, Italy, Portugal and Spain.

Cellular Goods has opened sales of its skincare products from its ecommerce website, which are all powered by the company's breakthrough anti-inflammatory CBG, for shipping to Austria, Italy, Portugal and Spain. The Company's products, including the best-selling Rejuvenating Face Serum, Rejuvenating Night Cream and Nourishing Face Oil, have been shown to visibly reverse the signs of skin ageing as effectively as retinol and vitamin C without the associated dryness and irritation.

Other products available for shipping to Austria, Italy, Portugal and Spain include the Company's SPF25 Rejuvenating Day Cream, Rejuvenating Day Mousse and Calming Cannabinoid After Shaving Moisturiser, as well as 'mini' sizes and gift sets.

All products are available for shipping to consumers in Austria, Italy, Portugal and Spain via the Company's ecommerce website, www.cellular-goods.com .

Darcy Taylor, Interim CEO, commented : "As we approach the peak Christmas shopping period, Cellular Goods is continuing its focus on increasing global access to our 'Look Better' skincare range within CBG friendly markets. We are pleased to have opened our ecommerce site to Austrian, Italian, Portuguese and Spanish customers, and we want to continue expanding distribution of our breakthrough anti-inflammatory CBG powered products to help increase brand awareness, gain traction with new customers and deliver incremental revenue growth."

For further information please contact:

 
 Cellular Goods 
 Darcy Taylor                        via FSCF [phone] 
  Chairman and Interim CEO 
                                    -------------------------- 
 First Sentinel Corporate Finance 
  (FSCF) 
                                    -------------------------- 
 Investor Relations 
  Rebecca Noonan                       [phone] 
  [e-mail] 
  Media Relations 
  Rebecca Noonan                       [phone] 
  [e-mail] 
  Corporate Broker & Advisor 
  Brian Stockbridge                    [phone] 
                                    -------------------------- 
 Novum Securities 
                                    -------------------------- 
 Corporate Broker 
  Colin Rowbury 
  Jon Belliss                          [phone] 
                                    -------------------------- 
 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDZMMMRKLGFZM

(END) Dow Jones Newswires

November 16, 2023 02:00 ET (07:00 GMT)